Fresenius Medical Care AG & Co. KGaA (FME) Given Average Recommendation of “Buy” by Analysts

Shares of Fresenius Medical Care AG & Co. KGaA (ETR:FME) have received an average rating of “Buy” from the nineteen research firms that are currently covering the company, MarketBeat reports. Eight investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is €84.02 ($97.70).

Several equities research analysts recently weighed in on the stock. Kepler Capital Markets set a €80.00 ($93.02) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Thursday, May 2nd. Barclays set a €71.00 ($82.56) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research report on Tuesday, April 30th. UBS Group set a €82.00 ($95.35) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Thursday, May 2nd. Nord/LB set a €92.00 ($106.98) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Friday, May 3rd. Finally, Deutsche Bank set a €100.00 ($116.28) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Friday, April 26th.

FME traded down €1.40 ($1.63) during trading hours on Thursday, hitting €72.60 ($84.42). The company’s stock had a trading volume of 840,908 shares, compared to its average volume of 704,197. Fresenius Medical Care AG & Co. KGaA has a 12 month low of €55.44 ($64.47) and a 12 month high of €91.74 ($106.67). The stock has a market capitalization of $22.06 billion and a PE ratio of 11.26. The company has a debt-to-equity ratio of 58.49, a quick ratio of 0.96 and a current ratio of 1.25.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Recommended Story: Fibonacci Channel

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.